[Choriocarcinoma]

Rofo. 2006 Dec;178(12):1261-3. doi: 10.1055/s-2006-927013.
[Article in German]
No abstract available

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Choriocarcinoma* / blood
  • Choriocarcinoma* / diagnosis
  • Choriocarcinoma* / drug therapy
  • Choriocarcinoma* / secondary
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Magnetic Resonance Imaging
  • Postpartum Period
  • Pregnancy
  • Radiography, Thoracic
  • Risk Factors
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Uterine Neoplasms* / blood
  • Uterine Neoplasms* / diagnosis
  • Uterine Neoplasms* / drug therapy

Substances

  • Chorionic Gonadotropin, beta Subunit, Human
  • Etoposide
  • Cisplatin